![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Multiple Sclerosis |
|
Free Subscription
2 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Attitudes towards vaccination in multiple sclerosis: insights from patients,
neurologists, and general practitioners within a qualitative study.
BMC Neurol. 2026;26:697.
PubMed
Abstract available
Mitochondrial Haplogroup U and multiple sclerosis risk in Arab and Near Eastern
populations: a systematic review and meta-analysis.
BMC Neurol. 2026;26:685.
PubMed
Abstract available
Treating Depression in Multiple Sclerosis with Transcranial Magnetic Stimulation:
A Pilot Study.
Can J Neurol Sci. 2026 Nov 5:1-6. doi: 10.1017/cjn.2026.10715.
PubMed
Abstract available
Enhancing Treg persistence by inhibiting necroptosis restrains autoimmune
pathology.
J Clin Invest. 2026;136:e207077.
PubMed
Abstract available
Uncovering disability progression in people with multiple sclerosis: a practical
guide.
J Neurol. 2026;273:699.
PubMed
Abstract available
Balo's concentric sclerosis: Longitudinal analysis of 20 patients revealing a
clinical phenotype distinct from multiple sclerosis.
J Neurol Sci. 2026;491:126227.
PubMed
Abstract available
Real-world evidence of diagnosis, treatment, and disease characteristics among
Japanese patients with multiple sclerosis: The Multiple Sclerosis Epidemiological
Retrospective Japan (MSERJ) study.
J Neurol Sci. 2026;491:126205.
PubMed
Abstract available
Pelvic neurology meets multiple sclerosis.
Mult Scler. 2026 Nov 4:13524585261501838. doi: 10.1177/13524585261501838.
PubMed
Lower recorded prevalence of Alzheimer's disease in natalizumab-exposed older
adults with multiple sclerosis: A hypothesis-generating observation.
Mult Scler. 2026 Nov 3:13524585261499995. doi: 10.1177/13524585261499995.
PubMed
Abstract available
Multiple sclerosis relapse redefined: Effect of an MRI-supported relapse
criterion on ublituximab outcomes in the ULTIMATE I and II trials.
Mult Scler. 2026 Nov 3:13524585261499629. doi: 10.1177/13524585261499629.
PubMed
Abstract available
Emergence of natalizumab anti-drug antibodies during extended interval dosing in
a patient with multiple sclerosis: A case report.
Mult Scler. 2026 Nov 2:13524585261500350. doi: 10.1177/13524585261500350.
PubMed
Abstract available
Impact of 2024 Revisions of Multiple Sclerosis Diagnostic Criteria in People With
Radiologically Isolated Syndrome.
Neurology. 2026;107:e218691.
PubMed
Abstract available
Toward a Biology-Driven Diagnosis of Multiple Sclerosis: What the 2024 McDonald
Criteria Mean for Radiologically Isolated Syndrome.
Neurology. 2026;107:e218758.
PubMed
Occupational Exposure to Petroleum-Derived Lubricants and Risk of Multiple
Sclerosis.
Neurology. 2026;107:e218718.
PubMed
Abstract available
Timing Is Everything: Occupational Petrolatum-Based Lubricant Exposure and
Multiple Sclerosis.
Neurology. 2026;107:e218747.
PubMed
[Spasticity in Multiple Sclerosis: 2026 Expert Consensus].
Rev Neurol. 2026;81:51172.
PubMed
Abstract available
Yellow fever vaccination in multiple sclerosis: A retrospective single-centre
case series.
Rev Neurol (Paris). 2026 Nov 4:S0035-3787(26)00620.
PubMed
Abstract available
Thank you for your interest in scientific medicine.